Since p53 can directly influence expression of the TLR gene family and downstream immune/inflammatory responses [24–26], understanding the relationship between p53 and its mutants with the immune system is expected to be important for addressing tumor progression and therapeutic approaches, especially since many therapies result in DNA damage and induction of available p53. This evidence concerns the gene TP53 and neoplasm.